Enrico Campadelli

Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial

Lucia Del Mastro, Mauro Mansutti, Giancarlo Bisagni et al. · The Lancet Oncology · 2021 · 86 citations

Medicine, Oncology, Breast Oncology +14

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study

Orazio Caffo, Ugo De Giorgi, Lucia Fratino et al. · European Urology · 2014 · 83 citations · Full text

Medicine, Oncology, Urology +12

PSA Flare With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer

Salvatore Luca Burgio, Vincenza Conteduca, Britt Rudnas et al. · Clinical Genitourinary Cancer · 2014 · 68 citations

Medicine, Oncology, Urology +13

Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, <i>ERBB2</i>-Negative Metastatic Breast Cancer

Elisabetta Munzone, Meredith M. Regan, Saverio Cinieri et al. · JAMA Oncology · 2023 · 33 citations · Full text

Medicine, Oncology, Pharmacology +16

Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme

Francesca Maines, Orazio Caffo, Ugo De Giorgi et al. · Clinical Genitourinary Cancer · 2015 · 21 citations

Medicine, Oncology, Pharmacology +16